Advocacy and Policy

accelerate header large-01

As the leader in global health innovation, we work with our partners to inform policies that accelerate the development and introduction of lifesaving vaccines, drugs, diagnostics, devices, and system and service innovations. We identify barriers to product development and the policy opportunities and actions to overcome them, and we convene diverse stakeholders to attract and align donor commitments to health research and development (R&D).

square placeholder-01

Educating US Congress on need for global health research and development

PATH educates members of US Congress about the need to invest in global health R&D to save lives around the world, protect Americans at home, and drive economic growth. Read the fact sheet >>

square placeholder-01

Building support for health research and innovation in the post-2015 agenda

We worked with our partners to publish a paper outlining why R&D of health tools for diseases and conditions affecting low- and middle-income countries should be a critical component of the post-2015 development agenda. Read the blog post >>

square placeholder-01

Supporting the global IC2030 initiative to accelerate innovation

PATH’s Innovation Countdown 2030 (IC2030) aims to accelerate progress toward solving the world’s most urgent health issues by 2030. We work to make sure policy makers are aware of the importance of innovation like those listed in report to reach global goals. Read the report >>